Johnson & Johnson Coronavirus Vaccine Wins FDA Authorization
The big pharmaceutical company's jab has some important advantages.
Cronos Group Slides on Q4 Results
The company's mixed quarter saw it trounce revenue estimates, but fall short of profitability forecasts.
Why AnaptysBio Was a Stock Market Star on Friday
There was some encouraging news from across the Atlantic.
Why Root Was a Flop on Friday
The company's Q4 performance fell short of expectations.
Why Select Medical Holdings Is Blasting 20% Higher Today
Critical care hospitalizations were up during the quarter, for obvious reasons.
Beyond Meat Signs Supply Deals With McDonald's and Yum! Brands, Releases Q4 Results
It was a good news, bad news kind of day for the alt-protein purveyor.
Southwest Airlines Adds 2 New Strategic Routes
Travelers will soon be able to hop on the company's planes and fly to Montana or the Florida panhandle.
Apple Expanding Its Presence in Target Stores
The "enhanced Apple shopping experience" will start to be introduced in the next few days.
Why Airbnb Is a Hot Stock After-Hours Today
The company posts a massive revenue beat for its Q4, although its net loss was deeper than anticipated.
Why Green Thumb Industries Rose on Thursday Before Tanking by 5%
Jolts of optimism from two analysts can't overcome a downbeat day for the market.
Why Pandion Therapeutics Stock Blasted Sky-High on Thursday
You'd vault into the air too if a big-name pharmaceutical paid a high premium for your stock.
Robinhood Fires Back at Berkshire Hathaway's Charlie Munger Over Criticism
The trading platform operator essentially accuses the Berkshire Hathaway vice chairman of being out of touch and elitist.
Moderna's Market Value Set to Rise by at Least 75%, Says Noted Analyst
Oppenheimer's Hartaj Singh believes the stock's market capitalization is headed to at least $100 billion.
Innovative Industrial Properties Misses on Q4 Results
The stock is being punished for not hitting analyst revenue and earnings estimates.
Costco Lifting Minimum Wage to $16 Per Hour, $1 Over Amazon, Walmart, and Target
It's also $1 higher than President Joe Biden's proposed hike.
Why Halozyme Therapeutics Is Trading 14% Higher Today
Investors liked what they saw in the company's fourth-quarter earnings release.
Why Co-Diagnostics Stock Is Shooting Higher Today
Its technology underpins a coronavirus test that's about to get much wider distribution.
Canopy Growth Is Poised to Fall by 35%, Says Analyst
The company isn't the best play on eventual U.S. decriminalization/legalization, according to a Jefferies prognosticator.
Report: AT&T Close to Selling Stake in DIRECTV, TV Now, and U-Verse Business Business
The deal could be worth around $15 billion.
Co-Diagnostics Names New CFO and CSO
With the latter appointment, the company's founder moves into a more advisory role.